The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of MEDI0639 in patients with advanced solid tumors.
 
Gerald Steven Falchook
Research Funding - AstraZeneca (Inst); MedImmune (Inst)
 
Afshin Dowlati
No Relationships to Disclose
 
Aung Naing
No Relationships to Disclose
 
Matthew Joseph Gribbin
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
Research Funding - MedImmune
 
David William Jenkins
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Linda L Chang
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Dominic W Lai
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
David C. Smith
Research Funding - Abraxis BioScience (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Atterocor (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb/Medarex (Inst); Celgene (Inst); Debiopharm Group (Inst); Eisai (Inst); Exelixis (Inst); ImClone Systems (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Millennium (Inst); Oncogenex (Inst); OncoMed (Inst); PSMA Development Company (Inst); Tekmira (Inst); Teva (Inst)